You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The DxN Veris was recently launched as a CE-marked product with a menu of viral load tests, and will launch in a few years in the US with STD and HAI assays.
Researchers reported on findings from analyses on whole-genome sequences and other features from three fowl adenoviruses found in China during 2012 or 2013.
The company is developing a prototype system that it aims to later validate in clinical samples.
In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.
In Cell this week: GWAS with immunophenotyping to examine genetic architecture of the immune system, hepatitis C virus sequesters miR-122 during infection, and more.
The findings also provide new clues about the virus' well-established association with hepatocellular carcinoma.
The new company will be focused entirely on hepatitis B, although officials previously said that Tekmira's other non-HBV RNAi programs would continue to advance.
The new assay expands a portfolio of viral load monitoring tests for the Cobas 6800 and 8800 systems.
The company provided updates for its hepatitis C and Alport syndrome candidates, which are both set to enter Phase II testing this year.
The company also recently paid $7 million for an exclusive option on an undisclosed RNAi technology and related intellectual property.
The Chan Zuckerberg Biohub is working with California's health department to sequence viral samples from COVID-19 patients to trace viral introductions, according to the San Francisco Chronicle.
Despite differences in their migration habits, eastern and western monarch butterflies are genetically similar, according to a study in Molecular Ecology.
The UK is implementing COVID-19 testing with a 90-minute turnaround time.
In PLOS this week: identification of fungal species in subcutaneous infections, sequencing of Campylobacter found in raw meat from retail stores, and more.